Skip to main navigation
Olema Oncology
  • Home
  • About
  • Science
    • Publications
    • Pipeline
    • Patients
    • Investors & Media
    • Careers
      • Culture
      • Contact
      • Privacy Policy
      • Terms of Use
      • Linkedin logo
      • Twitter logo
      coastal cliff

      SEC Filing Details

      • Investor Home
      • News & Events
        News Releases Events and Presentations
      • Stock
        Stock Quote & Chart Historic Price Lookup Investment Calculator
      • Corporate Governance
        Documents & Charters Board of Directors Management Committee Composition
      • Financials & Filings
        SEC Filings Quarterly Results
      • Investor Resources
        FAQs Email Alerts Analyst Coverage RSS Feeds Contact IR

      Document Details

      Form
      10-Q
      Filing Date
      May 9, 2022
      Document Date
      Mar 31, 2022
      Form Description
      Quarterly report which provides a continuing view of a company's financial position
      Filing Group
      Quarterly Filings
      Company
      Olema Oncology
      Issuer
      Olema Pharmaceuticals, Inc.

      Filing Formats

      iXBRL
      View HTML
      Download PDF
      Download DOC
      Download XLS

      XBRL

      XBRL Viewer
      EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
      EX-101.CAL - EX-101.CAL
      EX-101.DEF - EX-101.DEF
      EX-101.LAB - EX-101.LAB
      EX-101.PRE - EX-101.PRE
      XML - XBRL INSTANCE DOCUMENT
      • Print Page
      • Contact IR
      • RSS
      • Email Alerts
      Olema Oncology

      Onto something bigger, together.

      Join Us

      San Francisco

      512 2nd St., 4th Floor

      San Francisco, CA 94107

      Cambridge

      245 Main Street, 4th Floor

      Cambridge, MA 02142

      Contact

      info@olema.com

      • Linkedin logo
      • Twitter logo
      • ©2023 Olema Oncology. Olema, Olema Oncology and our logo are trademarks of Olema Oncology.    All rights reserved.

      • Privacy Policy
      • Terms of Use
      • Facebook
      • Twitter
      • LinkedIn
      • Google+